Page last updated: 2024-08-21

alpha-aminopyridine and Cutaneous T-Cell Lymphoma

alpha-aminopyridine has been researched along with Cutaneous T-Cell Lymphoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Afghani, S; Ai, WZ; Balassanian, R; Bandyopadhyay, S; Gao, HX; Gill, R; McCormick, F; Moasser, M; Pincus, L; Rakhshandehroo, T; Rubenstein, J; Wang, L; Wu, CH; Yang, CY	1
Dong, M; Fan, Y; Feng, J; Hong, X; Huang, H; Ke, X; Li, W; Lu, X; Ning, Z; Qi, J; Shen, Z; Shi, Y; Yu, L; Zhang, W; Zhao, X; Zhou, D; Zhu, J	1

Trials

1 trial(s) available for alpha-aminopyridine and Cutaneous T-Cell Lymphoma

Article	Year
Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:8 Topics: Adult; Aged; Aminopyridines; Antineoplastic Agents; Benzamides; Disease-Free Survival; Enteropathy-Associated T-Cell Lymphoma; Female; Histone Deacetylase Inhibitors; Humans; Leukopenia; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Mycosis Fungoides; Neoplasm Recurrence, Local; Neutropenia; Skin Neoplasms; Thrombocytopenia; Treatment Outcome; Young Adult	2015

Article

Year

Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:8

Topics: Adult; Aged; Aminopyridines; Antineoplastic Agents; Benzamides; Disease-Free Survival; Enteropathy-Associated T-Cell Lymphoma; Female; Histone Deacetylase Inhibitors; Humans; Leukopenia; Lymphoma, Extranodal NK-T-Cell; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Mycosis Fungoides; Neoplasm Recurrence, Local; Neutropenia; Skin Neoplasms; Thrombocytopenia; Treatment Outcome; Young Adult

2015

Other Studies

1 other study(ies) available for alpha-aminopyridine and Cutaneous T-Cell Lymphoma

Article	Year
Cutaneous T-Cell Lymphoma PDX Drug Screening Platform Identifies Cooperation between Inhibitions of PI3Kα/δ and HDAC. The Journal of investigative dermatology, 2021, Volume: 141, Issue:2 Topics: Aminopyridines; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Circulating Tumor DNA; Class I Phosphatidylinositol 3-Kinases; Drug Synergism; Female; Gene Knockdown Techniques; High-Throughput Screening Assays; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Lymphoma, T-Cell, Cutaneous; Mice; Morpholines; Protein Kinase Inhibitors; Skin; Skin Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays	2021

Article

Year

Cutaneous T-Cell Lymphoma PDX Drug Screening Platform Identifies Cooperation between Inhibitions of PI3Kα/δ and HDAC.

The Journal of investigative dermatology, 2021, Volume: 141, Issue:2

Topics: Aminopyridines; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Circulating Tumor DNA; Class I Phosphatidylinositol 3-Kinases; Drug Synergism; Female; Gene Knockdown Techniques; High-Throughput Screening Assays; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Lymphoma, T-Cell, Cutaneous; Mice; Morpholines; Protein Kinase Inhibitors; Skin; Skin Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays

2021